Evaluating an Early-Stage Deal Like a Pro

​Webinar Overview

​Join us for an inside look at the VC decision-making process, from assessing market potential to identifying key risks and structuring deals for long-term success. Learn what professional investors look for in early-stage healthcare companies and how a disciplined approach drives better outcomes.

​What You'll Learn:

• ​How VCs assess startups – Market potential, business model, and founding team

• ​Deal structure & terms – Why valuation, round composition, and investor participation matter

• ​Red flags & risks – Common warning signs early-stage investors watch for

​Can’t join us live? Register to receive the recording.

​About the Hosts:

• ​​Dr. Joseph Jasser is an accomplished Healthcare Executive with extensive leadership experience across multiple aspects of the healthcare industry, focusing on value-based care, large multi-specialty medical groups, integrated delivery systems, and clinical organizations.
  Dr. Jasser brings 20+ years of experience working with industry leaders like Humana, Signify Health, and Cleerly Health. He has served in critical leadership roles and is actively engaged as a venture advisor, advancing innovation across multiple healthcare organizations.

• ​​Tracy Poole is an attorney with over 30 years of experience in complex commercial transactions, M&A, financing, energy, hedge fund and venture capital disciplines. Tracy was corporate and outside counsel to leading energy marketing and trading companies and helped close some of the largest wholesale energy transactions in existence. He is the former General Counsel of a large energy-related hedge fund and the founder and operator of an independent upstream oil and gas producer with multiple exits. Tracy has been investing in early-stage companies for more than 20 years.

​For more information reach out to klynn@46.capital